Cardiff Oncology Inc (CRDF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Sales | 41 | 243 | 120 | 121 | 109 |
| Gross Profit | 41 | 243 | 120 | 121 | 109 |
| Operating Expenses | 12,891 | 8,070 | 12,094 | 14,898 | 14,491 |
| Operating Income | -12,850 | -7,827 | -11,974 | -14,777 | -14,382 |
| Other Income | 505 | 611 | 716 | 834 | 948 |
| Pre-tax Income | -12,345 | -7,216 | -11,258 | -13,943 | -13,434 |
| Net Income Continuous | -12,345 | -7,216 | -11,258 | -13,943 | -13,434 |
| Net Income | $-12,345 | $-7,216 | $-11,258 | $-13,943 | $-13,434 |
| EPS Basic Total Ops | -0.18 | -0.11 | -0.17 | -0.21 | -0.20 |
| EPS Basic Continuous Ops | -0.18 | -0.11 | -0.17 | -0.21 | -0.20 |
| EPS Diluted Total Ops | -0.18 | -0.11 | -0.17 | -0.21 | -0.20 |
| EPS Diluted Continuous Ops | -0.18 | -0.11 | -0.17 | -0.21 | -0.20 |
| EPS Diluted Before Non-Recurring Items | N/A | -0.11 | -0.17 | -0.21 | -0.20 |
| EBITDA(a) | $-12,856 | $-7,457 | $-12,137 | $-14,984 | $-14,426 |